Background The value of serum biomarkers, particularly alpha-fetoprotein (AFP) and protein
induced by vitamin K absence or antagonist-II (PIVKA-II), gains increasing attention in …

Abstract Background Resection of Barcelona Clinic Liver Cancer (BCLC) intermediate-stage
hepatocellular carcinoma (HCC) remains controversial. While not recommended by the …

Background Preoperative α-fetoprotein (AFP) levels may have an influence on disease-free
survival (DFS) of patients after liver transplantation for hepatocellular carcinoma (HCC) …

BACKGROUND: Antiangiogenic therapy has become the most important treatment modality
for patients with advanced hepatocellular carcinoma (HCC). In this study, the authors …

Serum alpha-fetoprotein (AFP) value is still not included in the consensus guidelines to
make decisions referring to liver transplantation (LT) for hepatocellular carcinoma (HCC) …

Liver transplantation (LT) for cirrhotic/Hepatocellular carcinoma (HCC) is associated with
reduced survival in patients with poor histological features. Preoperative levels of …

Alpha-fetoprotein (AFP) represents the most important biomarker for hepatocellular
carcinoma (HCC). The aim of this study was to identify the optimal staging system to predict …

We aimed to determine whether combining serum alpha‐fetoprotein (AFP) level with
hepatocellular carcinoma (HCC) tumor burden would allow better stratification of …

Background Currently, there is still a lack of effective biomarkers for the recurrence
monitoring and survival prognosis assessment of hepatocellular carcinoma (HCC) patients …

Purpose Alpha-fetoprotein (AFP) is considered to be an indicator of tumor activity in
hepatocellular carcinoma (HCC). We present a novel correlation of AFP response to …